Follow
MUHAMMAD HUZAIMI HARON
MUHAMMAD HUZAIMI HARON
Department of Pharmacology, Faculty of Medicine, Universiti Teknologi MARA
Verified email at uitm.edu.my
Title
Cited by
Cited by
Year
Nanoscale drug delivery systems and the blood–brain barrier
R Alyautdin, I Khalin, MI Nafeeza, MH Haron, D Kuznetsov
International journal of nanomedicine 9, 795, 2014
2602014
Natural product-based nanomedicine: Recent advances and issues for the treatment of Alzheimer's disease
CK Woon, WK Hui, R Abas, MH Haron, S Das, TS Lin
Current Neuropharmacology 20 (8), 1498-1518, 2022
32022
Effects of adding tocotrienol-tocopherol mixed fraction and vitamin C supplementation on coronary risk biomarkers in patients with hypercholesterolaemia with moderate coronary risk
MT Osman, AA Razak, H Haron, T Rahman, S Muid, TST Ismail, AS Ramli, ...
Journal of Applied Pharmaceutical Science 6 (4), 133-138, 2016
22016
Image Data Compression Using Discrete Cosine Transform Technique for Wireless Transmission.
MH Haron, MN Isa, MI Ahmad, RC Ismail, N Ahmad
International Journal of Nanoelectronics & Materials 14, 2021
12021
Tocilizumab as a Treatment for Cytokine Storm in COVID-19 Patients: A systematic review
MH Haron, MR Isa, HS Mohd Rashid, NA Adam, NA Awang, ...
J Pub Health Issue Pract 6 (1), 204, 2022
2022
Association of TCF7L2 Variants with Type 2 Diabetes Mellitus Susceptibility and Treatment Outcome in Multi-ethnic Malaysian Population
MH Haron
Department of Pharmacology, Faculty of Medicine, University of Malaya, 2012
2012
Association of tcf7l2 variants with type 2 diabetes mellitus susceptibility and treatment outcome in a multi-ethnic Malaysian population/Muhammad Huzaimi Bin Haron
H Muhammad Huzaimi
University of Malaya, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–7